Enveric Biosciences Inc vs Vanguard Growth Index Fund ETF — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Vanguard Growth Index Fund ETF trades at $87.22. The key difference: Vanguard Growth Index Fund ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | VUG | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $90.29 |
52-Week Low | $1.28 | $70.00 |
Enterprise Value | $408.82K | — |
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →